-
admin
Posts
Crystal Intelligence and Banxa Announce Strategic Partnership to Enhance Compliance for Embedded Crypto Solutions
Banxa’s strengthening of its compliance capabilities comes amid new measures introduced by Australian crypto regulations MELBOURNE, Australia, Dec. 17, 2024 /PRNewswire/ — Crystal Intelligence, a...
AI in 2025: Transforming the B2B Sales Landscape
MELBOURNE, Australia, Dec. 17, 2024 /PRNewswire/ — As we move into 2025, the potential of AI is reshaping how sales teams operate, engage, and deliver...
MMA Global Announces the SMARTIES™ X Global & North America 2024 Winners: A Celebration of Marketing Excellence – Pushing Innovative Boundaries on the Global Stage
NEW YORK, Dec. 17, 2024 /PRNewswire/ — MMA Global proudly announces the winners of the esteemed SMARTIES™ X Global & North America 2024 Awards. This...
Peabody Announces First Coal Shipment from Centurion Mine
Marks another major milestone in the redevelopment of the premium steelmaking coal mine ST. LOUIS, Dec. 17, 2024 /PRNewswire/ — Peabody (NYSE: BTU) today announced that it...
Video: CEO presentation at Minesto’s Capital Market Day 2024
The CEO presentation from Minesto’s Capital Market Day is now available on the company’s website and YouTube channel. The Capital Market Day was held on...
Precision Neuroscience Raises $102 Million to Advance AI-Powered Brain Implant
Series C Funding Round Establishes Precision as the Best-Funded Brain–Computer Interface Company After Neuralink The raise brings Precision’s total funding to $155 million, solidifying its...
Hydreight Updates on VSDHOne: Revolutionizing Direct-to-Consumer Healthcare Across All 50 States
VANCOUVER, British Columbia and LAS VEGAS, Dec. 16, 2024 (GLOBE NEWSWIRE) — Hydreight Technologies Inc. (“Hydreight”or the “Company”)(TSXV: NURS)(OTCQB: HYDTF)(FSE: SO6), a fast-growing mobile clinical network...
Foghorn Therapeutics Provides Update on FHD-286 Clinical Development Program and Strategic Priorities
Objective clinical responses by standard response criteria observed in Phase 1 dose escalation trial for FHD-286 in combination with decitabine in patients with relapsed and/or...
Perennial General Hospital Tianjin, China’s First Wholly Foreign-Owned Private Tertiary General Hospital Will Soon Commence Operations
SINGAPORE, Dec. 16, 2024 /PRNewswire/ — Perennial Holdings Private Limited (“Perennial Holdings“) is pleased to announce that Perennial General Hospital in Tianjin city (“Perennial General Hospital...
Lockton Unveils New Global Parametric Insurance Practice
Lockton’s Global Parametric Insurance Practice is set to help businesses adopt cost-effective alternative risk solutions, addressing the widening gap between insured and uninsured losses. KANSAS...
